Skip to main content

Applied Molecular Transport Inc.

AMTIDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001801777

Applied Molecular Transport Inc. was delisted in 2023; its insiders filed their last Form 4 on Dec 29, 2023; 27 institutions reported holding it in 13F filings for Q3 2023, worth $2.44M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Applied Molecular Transport Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Applied Molecular Transport Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Applied Molecular Transport Inc.
NameTitleLast reported holdingLast filingFilings, past year
Epq LLC Amt PSOther: Owner0IndirectDec 29, 20230
Boeding ChadOther: CEO of Managing Member0IndirectDec 29, 20230
EPIQ Capital Group, LLCOther: Managing Member of 10% Owner0IndirectDec 29, 20230
Epq LLC, Amtb PSOther: owner0IndirectDec 29, 20230
Epq LLC, Amtc PSOther: owner0IndirectDec 29, 20230
Smither John WDirector–Dec 28, 20230
Cross ShawnCEO & Chair of the Board0Dec 28, 20230
Hants BrandonCFO0Dec 28, 20230
Mahmood Tahir Ph.D.Director0IndirectDec 28, 20230
VanDevender AaronDirector0Dec 28, 20230
Schachner Holly CarenDirector–Dec 28, 20230
Banard Charlene A.Director–Dec 28, 20230
Rich Douglas A.Chief Technical Officer49,316Mar 3, 20230
Kanwar BittooChief Medical Officer78,005Mar 3, 20230
Mrsny Randall Ph.D.Director21,136Dec 6, 20220
Lamond DavidDirector1,077,519IndirectMay 26, 20220
Bhatt ElizabethChief Bus. & Strategy Officer48,750Feb 16, 20220
Cooper Graham KDirector–Jan 31, 20220
Kim Helen SusanDirector575,000Aug 27, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 27, 2023 (view filing)4:52 PM ETNov 225 daysMahmood Tahir Ph.D.DirectorSSale−286.3K$0.1634−$46.8K−37.1%484.7K after
Nov 27, 2023 (view filing)4:47 PM ETNov 225 daysHants BrandonCFOSSale−61.5K$0.1635−$10.1K−17.0%301.2K after
Nov 24, 2023 (view filing)4:21 PM ETNov 222 daysCross ShawnCEO & Chair of the BoardSSale−110.8K$0.1635−$18.1K−16.9%545.5K after
Nov 16, 2023 (view filing)5:38 PM ETNov 151 dayHants BrandonCFOSSale−50.1K$0.1606−$8.05K−12.1%362.7K after
Nov 16, 2023 (view filing)5:36 PM ETNov 151 dayCross ShawnCEO & Chair of the BoardSSale−90.4K$0.1606−$14.5K−12.1%656.3K after
Oct 10, 2023 (view filing)5:02 PM ETOct 64 daysMahmood Tahir Ph.D.DirectorSSale−184.4K$0.1647−$30.4K−19.3%771.1K after
Oct 4, 2023 (view filing)7:30 PM ETJun 2-Sep 5124 daysLateMahmood Tahir Ph.D.DirectorSSale−4.24K$0.2234−$946.51−5.8%69.4K after2 lots
Oct 4, 2023 (view filing)7:28 PM ETJun 2-Sep 5124 daysLateHants BrandonCFOSSale−2.92K$0.2327−$679.68−0.7%412.9K after3 lots
Oct 4, 2023 (view filing)7:27 PM ETJun 2-Sep 5124 daysLateCross ShawnCEO & Chair of the BoardSSale−5.56K$0.2334−$1.30K−0.7%746.7K after4 lots
Oct 2, 2023 (view filing)7:10 PM ETSep 293 daysHants BrandonCFOSSale−107.5K$0.1585−$17.0K−20.5%415.8K after
Oct 2, 2023 (view filing)7:02 PM ETSep 293 daysCross ShawnCEO & Chair of the BoardSSale−194.0K$0.1585−$30.7K−20.5%752.3K after
Mar 3, 2023 (view filing)Mar 12 daysRich Douglas A.Chief Technical OfficerSSale−482$0.50−$241−1.0%49.3K after
Mar 3, 2023 (view filing)Mar 12 daysMahmood Tahir Ph.D.Chief Executive OfficerSSale−1.80K$0.50−$901−2.4%73.6K after
Mar 3, 2023 (view filing)Mar 12 daysKanwar BittooChief Medical OfficerSSale−539$0.50−$269.5−0.7%78.0K after
Mar 3, 2023 (view filing)Mar 12 daysHants BrandonCFOSSale−504$0.50−$252−1.5%32.3K after
Mar 3, 2023 (view filing)Mar 12 daysCross ShawnPresident & COOSSale−934$0.50−$467−1.5%60.2K after
Dec 6, 2022 (view filing)Dec 24 daysRich Douglas A.Chief Technical OfficerSSale−4.23K$1.05−$4.44K−7.8%49.8K after
Dec 6, 2022 (view filing)Dec 24 daysMrsny Randall Ph.D.DirectorSSale−418$1.05−$438.9−1.9%21.1K after
Dec 6, 2022 (view filing)Dec 24 daysMahmood Tahir Ph.D.Chief Executive OfficerSSale−1.77K$0.00$0−2.3%75.4K after
Dec 6, 2022 (view filing)Dec 24 daysKanwar BittooChief Medical OfficerSSale−3.49K$1.05−$3.66K−4.3%78.5K after
Dec 6, 2022 (view filing)Dec 24 daysHants BrandonCFOSSale−1.96K$1.05−$2.06K−5.6%32.8K after
Dec 6, 2022 (view filing)Dec 24 daysCross ShawnPresident & COOSSale−3.89K$1.05−$4.09K−6.0%61.1K after
Nov 29, 2022 (view filing)Nov 25-284 daysVanDevender AaronDirectorPPurchase+150.0K$1.00+$150.0K+239.4%212.7K after2 lots
Sep 6, 2022 (view filing)Sep 15 daysRich Douglas A.Chief Technical OfficerSSale−448$1.42−$636.16−0.8%54.0K after
Sep 6, 2022 (view filing)Sep 15 daysMrsny Randall Ph.D.DirectorSSale−404$1.42−$573.68−1.8%21.6K after
Sep 6, 2022 (view filing)Sep 15 daysMahmood Tahir Ph.D.Chief Executive OfficerSSale−1.72K$1.42−$2.45K−2.3%74.2K after
Sep 6, 2022 (view filing)Sep 15 daysKanwar BittooChief Medical OfficerSSale−503$1.42−$714.26−0.6%82.0K after
Sep 6, 2022 (view filing)Sep 15 daysHants BrandonCFOSSale−462$1.42−$656.04−1.3%34.8K after
Sep 6, 2022 (view filing)Sep 15 daysCross ShawnPresident & COOSSale−884$1.42−$1.26K−1.3%65.0K after2 lots
Jun 3, 2022 (view filing)Jun 1-22 daysRich Douglas A.Chief Technical OfficerSSale−4.72K$3.01−$14.2K−8.0%54.5K after2 lots
Jun 3, 2022 (view filing)Jun 1-22 daysMrsny Randall Ph.D.DirectorSSale−711$3.01−$2.14K−3.4%20.0K after2 lots
Jun 3, 2022 (view filing)Jun 1-22 daysMahmood Tahir Ph.D.Chief Executive OfficerSSale−3.08K$3.01−$9.25K−3.9%74.9K after2 lots
Jun 3, 2022 (view filing)Jun 1-22 daysKanwar BittooChief Medical OfficerSSale−3.99K$3.01−$12.0K−4.7%80.6K after2 lots
Jun 3, 2022 (view filing)Jun 1-22 daysHants BrandonCFOSSale−2.04K$3.01−$6.13K−5.8%33.3K after2 lots
Jun 3, 2022 (view filing)Jun 1-22 daysCross ShawnPresident & COOSSale−3.93K$3.01−$11.8K−5.6%65.9K after2 lots
May 23, 2022 (view filing)May 20-233 daysLamond DavidDirectorPPurchase+66.5K$3.17+$210.8K+6.6%1.08M after2 lots
May 16, 2022 (view filing)5:49 PM ETMay 12-134 daysEpq LLC Amt PS and 4 othersOther: OwnerPPurchase+62.1K$4.02+$249.8K+0.8%8.34M after2 lots
Mar 2, 2022 (view filing)Feb 28-Mar 12 daysVanDevender AaronDirectorPPurchase+50.0K$6.35+$317.7K+395.0%62.7K after2 lots
Jan 31, 2022 (view filing)Jan 283 daysMahmood Tahir Ph.D.Chief Executive OfficerPPurchase+3.00K$7.88+$23.6KNew position3.00K after
Dec 10, 2021 (view filing)Dec 91 dayMrsny Randall Ph.D.Chief Scientific OfficerPPurchase+3.50K$14.99+$52.5KNew position3.50K after
Nov 18, 2021 (view filing)3:41 PM ETNov 16-172 daysEpq LLC Amt PS and 3 othersOther: OwnerPPurchase+11.1K$22.45+$250.0K+0.1%8.28M after2 lots
Aug 27, 2021 (view filing)Aug 26-271 dayKim Helen SusanDirectorSSale−15.0K$30.20−$453.5K−2.5%575.0K after4 lots
Aug 25, 2021 (view filing)Aug 24-251 dayKim Helen SusanDirectorSSale−9.99K$30.08−$300.4K−1.7%590.0K after3 lots
Aug 23, 2021 (view filing)Aug 19-234 daysCross ShawnChief Financial OfficerSSale−10.0K$30.12−$301.2K−100.0%0 after2 lots
Jul 22, 2021 (view filing)Jul 211 dayBhatt ElizabethChief Bus. & Strategy OfficerSSale−9.00K$36.68−$330.1K−100.0%0 after2 lots
Jul 8, 2021 (view filing)Jul 71 dayKanwar BittooChief Medical OfficerSSale−7.50K$42.09−$315.7K−100.0%0 after3 lots
Jul 6, 2021 (view filing)Jul 24 daysKim Helen SusanDirectorSSale−200.0K$43.32−$8.66M−25.0%600.0K after2 lots